Okada Y
Department of Pathology, School of Medicine, Keio University, Tokyo, Japan.
Verh Dtsch Ges Pathol. 2007;91:29-38.
Morphogenesis of malignant tumors is characterized by proliferation, invasive growth and metastasis. Although these properties are determined mainly by genetic derangements, their biological behavior within tissues is strictly regulated by tumor microenvironment, which consists of extracellular matrix, proteinases, soluble factors (cytokines/growth factors/chemokines), stromal cells and blood vessels. Thus, modulation of the microenvironment is implicated in morphogenesis in tumorigenesis. ADAMs (a disintegrin and metalloproteinases) are a new gene family of membrane-anchored and secreted proteins that have proteolytic and/or adhesive properties. They are involved in biological events including cell adhesion, cell fusion, membrane protein shedding and proteolysis. We examined the expression of the proteinase-type ADAMs in the invasive breast and lung carcinoma tissues, and found that membrane-anchored ADAM28m and secreted ADAM28s are selectively overexpressed in activated forms by carcinoma cells. The mRNA expression levels directly correlated with the proliferative activity of the carcinoma cells in both carcinomas, and with lymph node metastasis in the lung carcinomas. Our experimental studies showed that ADAM28 plays a key role in cancer cell proliferation through enhancing bioavailability of insulin-like growth factor-I (IGF-I) released from the IGF-I/IGF-binding protein 3 (IGFBP-3) complex by selective cleavage of IGFBP-3. We also identified P-selectin glycoprotein ligand-1 (PSGL-1) as a binding protein to ADAM28 by yeast two-hybrid system, and demonstrated that ADAM28s promotes PSGL-1/P-selectin-mediated HL-60 cell rolling adhesion to endothelial cells and subsequent transendothelial migration into tissue spaces. Altogether, our data suggest the possibility that ADAM28 expressed by cancer cells is involved in cancer cell proliferation and metastases in human cancers through modulation of tumor microenvironment and cell adhesion.
恶性肿瘤的形态发生具有增殖、侵袭性生长和转移的特征。尽管这些特性主要由基因紊乱决定,但其在组织内的生物学行为受到肿瘤微环境的严格调控,肿瘤微环境由细胞外基质、蛋白酶、可溶性因子(细胞因子/生长因子/趋化因子)、基质细胞和血管组成。因此,微环境的调节与肿瘤发生中的形态发生有关。ADAMs(一种去整合素和金属蛋白酶)是一个新的膜锚定和分泌蛋白基因家族,具有蛋白水解和/或粘附特性。它们参与包括细胞粘附、细胞融合、膜蛋白脱落和蛋白水解在内的生物学事件。我们检测了蛋白酶型ADAMs在浸润性乳腺癌和肺癌组织中的表达,发现膜锚定的ADAM28m和分泌型ADAM28s在癌细胞中以活化形式选择性过表达。在这两种癌中,mRNA表达水平与癌细胞的增殖活性直接相关,在肺癌中与淋巴结转移相关。我们的实验研究表明,ADAM28通过选择性切割IGFBP-3增强从IGF-I/IGF结合蛋白3(IGFBP-3)复合物释放的胰岛素样生长因子-I(IGF-I)的生物利用度,从而在癌细胞增殖中起关键作用。我们还通过酵母双杂交系统鉴定了P-选择素糖蛋白配体-1(PSGL-1)为ADAM28的结合蛋白,并证明ADAM28s促进PSGL-1/P-选择素介导的HL-60细胞与内皮细胞的滚动粘附以及随后跨内皮迁移到组织间隙。总之,我们的数据表明,癌细胞表达的ADAM28可能通过调节肿瘤微环境和细胞粘附参与人类癌症中的癌细胞增殖和转移。